References
Perou CM et al (2000) Molecular portraits of human breast tumours. Nature 406(6797):747–752
Sorlie T et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98(19):10869–10874
van ‘t Veer LJ et al (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415(6871):530–536
Wood LD et al (2007) The genomic landscapes of human breast and colorectal cancers. Science 318(5853):1108–1113
Stephens PJ et al (2009) Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature 462(7276):1005–1010
Dowsett M et al (2007) International web-based consultation on priorities for translational breast cancer research. Breast Cancer Res 9(6):R81
Smid M et al (2010) Patterns and incidence of chromosomal instability and their prognostic relevance in breast cancer subtypes. Breast Cancer Res Treat. doi:10.1007/s10549-010-1026-5
Tran-Thanh D et al (2010) Amplification of the prolactin receptor gene in mammary lobular neoplasia. Breast Cancer Res Treat. doi:10.1007/s10549-010-1025-6
Bergamaschi A et al (2006) Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Genes Chromosom Cancer 45(11):1033–1040
Carter SL et al (2006) A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet 38(9):1043–1048
Dahiya R, Deng G (1998) Molecular prognostic markers in breast cancer. Breast Cancer Res Treat 52(1–3):185–200
Merkel DE, McGuire WL (1990) Ploidy proliferative activity and prognosis. DNA flow cytometry of solid tumors. Cancer 65(5):1194–1205
Ross JS et al (2003) Breast cancer biomarkers and molecular medicine. Expert Rev Mol Diagn 3(5):573–585
Allred DC (2010) Issues and updates: evaluating estrogen receptor-alpha, progesterone receptor, and HER2 in breast cancer. Mod Pathol 23(suppl 2):S52–S59
Gluz O et al (2009) Triple-negative breast cancer–current status and future directions. Ann Oncol 20(12):1913–1927
Sotiriou C et al (2006) Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 98(4):262–272
Smid M et al (2008) Subtypes of breast cancer show preferential site of relapse. Cancer Res 68(9):3108–3114
Allred DC, Brown P, Medina D (2004) The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer. Breast Cancer Res 6(6):240–245
Allred DC et al (2008) Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution. Clin Cancer Res 14(2):370–378
Hwang ES et al (2004) Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma. Cancer 100(12):2562–2572
Mastracci TL et al (2006) Genomic alterations in lobular neoplasia: a microarray comparative genomic hybridization signature for early neoplastic proliferation in the breast. Genes Chromosom Cancer 45(11):1007–1017
Author information
Authors and Affiliations
Corresponding author
Additional information
This is an invited commentary to articles doi:10.1007/s10549-010-1026-5, 10.1007/s10549-010-1025-6.
Rights and permissions
About this article
Cite this article
Gru, A., Craig Allred, D. High-resolution analyses of gene copy number reveal new insights into the prognosis and progression of breast cancers. Breast Cancer Res Treat 128, 41–43 (2011). https://doi.org/10.1007/s10549-010-1146-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-010-1146-y